Verastem | VSTM - Ebit

金融业

USD

USD 246.44M

现金及等价物

USD 204.99M

USD 2.89M

USD 223.41M

USD 72.27M

USD 66.79M

股息收益率

0

USD -41.48M

USD -21.3M

73

EPS每股收益

USD -0.48

股本和储备

USD 57.2M

USD 14.64M

债务利息支出

USD 415K

USD 831K

USD 81.33M

USD 103.7M

USD -32.92M

USD 59.01M

USD -41.48M

普通股股本

USD 77.74M

USD -32.92M

USD 17.54M

销售和管理费用

USD 24.44M

USD 0

贸易债权人

USD 12.45M

应收帐款人

USD 9.01M

	Ebit	更改		日
AbbVie	USD 4.73B		1.08B	2026-03
Alaunos Therapeutics	USD -1.01M		175K	2026-03
AstraZeneca	USD 7.11B		4.14B	2026-03
Curis	USD -7.88M		4.31M	2025-12
Cytokinetics	USD -181.23M		2.86M	2026-03
Gilead Sciences	USD 2.68B		284M	2026-03
Incyte	USD 344.17M		39.71M	2026-03
Laboratory Of America	USD 410.1M		28.1M	2026-03
Novartis	USD 4.18B		118M	2026-03
Pfizer	USD 4.99B		340M	2026-03
Roche Holding	CHF 9.56B		2.1B	2025-12
TG Therapeutics	USD 34.8M		15.7M	2026-03
Verastem	USD -41.48M		4.44M	2025-12